CO5060468A1 - Empleo de derivados de tetrahidropiridinas (o 4-hidroxi-pipe ridinas)-butilazoles en la elaboracion de un medicamento par a el tratamiento del dolor - Google Patents
Empleo de derivados de tetrahidropiridinas (o 4-hidroxi-pipe ridinas)-butilazoles en la elaboracion de un medicamento par a el tratamiento del dolorInfo
- Publication number
- CO5060468A1 CO5060468A1 CO99041288A CO99041288A CO5060468A1 CO 5060468 A1 CO5060468 A1 CO 5060468A1 CO 99041288 A CO99041288 A CO 99041288A CO 99041288 A CO99041288 A CO 99041288A CO 5060468 A1 CO5060468 A1 CO 5060468A1
- Authority
- CO
- Colombia
- Prior art keywords
- atom
- carbon atom
- pain
- radical
- represented
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Empleo de un derivado de tetrahidropiridina (o 4-hidroxipiperidina)butilazol de fórmula general (I): donde R1 , R2 y R3 , idéntico o diferentes presentan cada uno de ellos un átomo de hidrógeno, un átomo de halógeno, un grupo alquilo C1 -C4 , un radical trifluorometilo, un radical hidroxilo o un radical alcoxilo, y además, dos radicales adyacentes pueden formar parte de un ciclo aromático de seis miembros; A representa un átomo de carbono y la línea punteada representa enlace adicional, o bien A representa un átomo de carbono unido a un grupo hidroxilo (C-OH) y la línea punteada representa carencia de enlace adicional; Z1 representa un átomo de nitrógeno o un átomo de carbono substituido que se puede representar por C-R4 ; Z2 representa un átomo de nitrógeno o un átomo de carbono substituido que se puede representar por C-R5 ; Z4 representa un átomo de nitrógeno o un átomo de carbono substituido que se puede representar por C-R7 ; con la condición de que Z1 , Z2 y Z4 en su conjunto pueden representar, como máximo, dos átomos de nitrógeno; y R4 , R5 , R6 y R7 , iguales o diferentes representan un átomo de hidrógeno, un átomo de halógeno, un grupo alquilo C1 -C4 , un radical arilo o arilo substituido, o bien dos radicales adyacentes pueden formar parte de un ciclo aromático de seis miembros; o una de sus sales fisiológicamente aceptables, en la elaboración de un medicamento para el tratamiento del dolor agudo, del dolor neuropático o del dolor nociceptivo en mamíferos, incluido el hombre.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009801467A ES2151828B1 (es) | 1998-07-10 | 1998-07-10 | Empleo de derivados de tetrahidropiridinas (ohidroxi-piperidinas)-b utilazoles en la elaboracion de un medicamento para el tratamiento del dolor. |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5060468A1 true CO5060468A1 (es) | 2001-07-30 |
Family
ID=8304473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO99041288A CO5060468A1 (es) | 1998-07-10 | 1999-07-01 | Empleo de derivados de tetrahidropiridinas (o 4-hidroxi-pipe ridinas)-butilazoles en la elaboracion de un medicamento par a el tratamiento del dolor |
Country Status (31)
Country | Link |
---|---|
US (2) | USRE39113E1 (es) |
EP (1) | EP1097698B1 (es) |
JP (1) | JP2002520261A (es) |
KR (1) | KR100758740B1 (es) |
CN (1) | CN1134259C (es) |
AR (1) | AR019894A1 (es) |
AT (1) | ATE239476T1 (es) |
AU (1) | AU747073C (es) |
BG (1) | BG64725B1 (es) |
BR (1) | BR9912000A (es) |
CA (1) | CA2336784A1 (es) |
CO (1) | CO5060468A1 (es) |
CZ (1) | CZ292015B6 (es) |
DE (1) | DE69907685T2 (es) |
DK (1) | DK1097698T3 (es) |
ES (2) | ES2151828B1 (es) |
HU (1) | HUP0102868A3 (es) |
ID (1) | ID28817A (es) |
IL (1) | IL140854A (es) |
MX (1) | MXPA01000369A (es) |
NO (1) | NO20010147L (es) |
NZ (1) | NZ509556A (es) |
PL (1) | PL194721B1 (es) |
PT (1) | PT1097698E (es) |
RU (1) | RU2202347C2 (es) |
SK (1) | SK372001A3 (es) |
TR (1) | TR200100043T2 (es) |
TW (1) | TW589317B (es) |
UA (1) | UA57149C2 (es) |
WO (1) | WO2000002519A2 (es) |
ZA (1) | ZA200100240B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6995144B2 (en) * | 2002-03-14 | 2006-02-07 | Eisai Co., Ltd. | Nitrogen containing heterocyclic compounds and medicines containing the same |
JP4521777B2 (ja) | 2003-07-24 | 2010-08-11 | ユーロ−セルティーク エス.エイ. | 疼痛治療または予防に有用な4−ヘテロアリール−テトラヒドロピペリジル化合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH084287A (ja) * | 1994-06-16 | 1996-01-09 | Tateyama Alum Ind Co Ltd | 柱体のコンクリート床面立設方法及びこれに用いる治具 |
FR2723091B1 (fr) * | 1994-07-29 | 1996-11-08 | Esteve Labor Dr | Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles |
WO1997035584A1 (en) * | 1996-03-25 | 1997-10-02 | Eli Lilly And Company | Method for treating pain |
-
1998
- 1998-07-10 ES ES009801467A patent/ES2151828B1/es not_active Expired - Fee Related
-
1999
- 1999-07-01 CO CO99041288A patent/CO5060468A1/es unknown
- 1999-07-07 AR ARP990103289A patent/AR019894A1/es unknown
- 1999-07-09 TR TR2001/00043T patent/TR200100043T2/xx unknown
- 1999-07-09 WO PCT/ES1999/000222 patent/WO2000002519A2/es not_active Application Discontinuation
- 1999-07-09 CZ CZ200175A patent/CZ292015B6/cs not_active IP Right Cessation
- 1999-07-09 AU AU46171/99A patent/AU747073C/en not_active Ceased
- 1999-07-09 DK DK99929333T patent/DK1097698T3/da active
- 1999-07-09 CA CA002336784A patent/CA2336784A1/en not_active Abandoned
- 1999-07-09 HU HU0102868A patent/HUP0102868A3/hu unknown
- 1999-07-09 NZ NZ509556A patent/NZ509556A/xx unknown
- 1999-07-09 RU RU2001103738/14A patent/RU2202347C2/ru not_active IP Right Cessation
- 1999-07-09 PT PT99929333T patent/PT1097698E/pt unknown
- 1999-07-09 BR BR9912000-3A patent/BR9912000A/pt not_active Application Discontinuation
- 1999-07-09 KR KR1020017000391A patent/KR100758740B1/ko not_active IP Right Cessation
- 1999-07-09 IL IL140854A patent/IL140854A/en not_active IP Right Cessation
- 1999-07-09 US US10/355,216 patent/USRE39113E1/en not_active Expired - Fee Related
- 1999-07-09 DE DE69907685T patent/DE69907685T2/de not_active Expired - Lifetime
- 1999-07-09 ID IDW20010066A patent/ID28817A/id unknown
- 1999-07-09 PL PL99345781A patent/PL194721B1/pl not_active IP Right Cessation
- 1999-07-09 SK SK37-2001A patent/SK372001A3/sk unknown
- 1999-07-09 EP EP99929333A patent/EP1097698B1/en not_active Expired - Lifetime
- 1999-07-09 JP JP2000558783A patent/JP2002520261A/ja not_active Ceased
- 1999-07-09 MX MXPA01000369A patent/MXPA01000369A/es active IP Right Grant
- 1999-07-09 CN CNB998102083A patent/CN1134259C/zh not_active Expired - Fee Related
- 1999-07-09 US US09/743,085 patent/US6384055B1/en not_active Ceased
- 1999-07-09 AT AT99929333T patent/ATE239476T1/de not_active IP Right Cessation
- 1999-07-09 ES ES99929333T patent/ES2198136T3/es not_active Expired - Lifetime
- 1999-08-10 TW TW088112508A patent/TW589317B/zh not_active IP Right Cessation
- 1999-09-07 UA UA2001010210A patent/UA57149C2/uk unknown
-
2001
- 2001-01-09 NO NO20010147A patent/NO20010147L/no not_active Application Discontinuation
- 2001-01-09 ZA ZA200100240A patent/ZA200100240B/en unknown
- 2001-01-10 BG BG105141A patent/BG64725B1/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0010476A (pt) | Compostos derivados do 4,5,6,7-tetrahidroindazol e seu uso como agentes antitumorais | |
CO6341631A2 (es) | Derivados de 1,2,4 - oxadiazol y su uso terapéutico | |
HUP0105414A2 (hu) | Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
NO20071137L (no) | Nye piperidinderivater for behandling av depresjon | |
ES2054860T5 (es) | Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos. | |
CY1105250T1 (el) | Μεθοδος θepαπευτικης αγωγης καταστασεων σχετιζομενων με κιναση ρ38 και ενωσεις πυρρολοτριαζινης χρησιμες ως αναστολεις της κινασης | |
CY1106674T1 (el) | Αζαδικυκλικοι ετεροκυκλοι σαν ρυθμιστες υποδοχεα κανναβινοειδους | |
TR200201317T2 (tr) | Sinerjistik kombinasyon. | |
BRPI0313942C1 (pt) | derivados de benzimidazol úteis como agentes antiproliferativos, seus processos de preparação, composição farmacêutica compreendendo os mesmos e usos dos referidos compostos nas preparações de composições farmacêuticas | |
HUP9700997A1 (hu) | Benzimidazolszármazékok és e vegyületeket tartalmazó, antihisztamin hatású gyógyászati készítmények | |
NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
AR045040A1 (es) | Derivados de compuestos espiroazabiciclicos, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos | |
AR039256A1 (es) | Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos | |
BR0308338A (pt) | Derivados de nitrosodifenilamina e seu uso farmacêutico contra patologias de estresse oxidativo | |
AR036864A1 (es) | Uso de compuestos de acido benzacepin-n-acetico, y procedimiento para la preparacion de dichos compuestos | |
NO20001781L (no) | 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse | |
UY28536A1 (es) | Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos. | |
NO20063619L (no) | Diarylmetylpiperazinderivater, fremstilling og anvendelse derav | |
CY1105786T1 (el) | Εκδοχα φλαβονων η διαδικασια παρασκευης τους, η εφαρμογη τους ως φαρμακα | |
CO5160242A1 (es) | UTILIZACION DE DERIVADOS DE PIRIDAZINO [4,5-b] INDOL-1- ACETAMIDA, PARA LA PREPARACION DE MEDICAMENTOS DESTINADOS A LAS ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL | |
PA8531701A1 (es) | Derivados de pirimidina | |
UY27651A1 (es) | Nuevas composiciones de medicamentos que, junto a agentes colinérgicos, contienen compuestos heterocíclicos | |
ES2186212T3 (es) | Compuesto farmaceutico. | |
TW200628450A (en) | Pyridine derivatives, preparation thereof and therapeutic application thereof |